Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1985-4-17
|
| pubmed:abstractText |
LH and FSH of cerebrospinal fluid (CSF) and serum were radioimmunologically measured. Samples were obtained simultaneously from 116 subjects of the following groups: A. 22 patients with non-endocrine diseases, B. 18 patients with cranial diabetes insipidus (DI) of whom 4 with metastatic carcinomas, C. 5 patients with primary empty sella syndrome, D. one with hydatiform mole, and E. 70 patients with pituitary adenomas, i.e. growth hormone--or prolactin-secreting or "non-secreting" adenomas, of whom 38 patients with invasive and 32 with enclosed adenomas. LH and FSH are normal constituents of CSF and their CSF levels poorly correlates with the serum ones (LH r = 0.477 p less than 0.01). Enclosed adenomas with SSE showed low levels of LH in CSF. High CSF-gonadotropins concentrations (above 4.0 mIU/ml) with a low serum/CSF ratio (below 3) was frequently, but not constantly found in patients with invasive adenomas and are not indicative per se of this diagnosis. Some patients with brain metastasis from breast carcinoma and DI, or with non-tumoral diseases and DI showed similar high patterns of CSF gonadotropins though the serum levels were within normal range. This suggests that local vascular mechanisms, including the retrograde circulation of gonadotropins from the pituitary to the hypothalamus, influence the blood-brain barrier much more than the release of gonadotropins into the systemic blood circulation.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1011-6206
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
21-37
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:3919406-Acromegaly,
pubmed-meshheading:3919406-Adenoma,
pubmed-meshheading:3919406-Adolescent,
pubmed-meshheading:3919406-Adult,
pubmed-meshheading:3919406-Blood-Brain Barrier,
pubmed-meshheading:3919406-Diabetes Insipidus,
pubmed-meshheading:3919406-Empty Sella Syndrome,
pubmed-meshheading:3919406-Female,
pubmed-meshheading:3919406-Follicle Stimulating Hormone,
pubmed-meshheading:3919406-Humans,
pubmed-meshheading:3919406-Hydatidiform Mole,
pubmed-meshheading:3919406-Luteinizing Hormone,
pubmed-meshheading:3919406-Male,
pubmed-meshheading:3919406-Middle Aged,
pubmed-meshheading:3919406-Pituitary Neoplasms,
pubmed-meshheading:3919406-Pregnancy,
pubmed-meshheading:3919406-Prolactin,
pubmed-meshheading:3919406-Radioimmunoassay,
pubmed-meshheading:3919406-Uterine Neoplasms
|
| pubmed:articleTitle |
LH and FSH in human cerebrospinal fluid.
|
| pubmed:publicationType |
Journal Article
|